G. Steven Burrill in conversation with Arnold Thackray
On April 11, 2012, renowned biotech investment guru and entrepreneur G. Steven Burrill and CHF chancellor Arnold Thackray discussed the next frontiers of biotechnology in History Live: The Changing World of Biotech.
Burrill predicts that the United States will soon move into a “wellness care” system, based on a convergence of new technologies that improve outcomes for patients. As these changes occur, great portions of today’s health-care system will become obsolete, and new opportunities will open up for investment and research.
G. Steven Burrill
G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. An early biotech pioneer, Burrill is an original architect of the industry and one of its most avid and sustained developers. He is currently CEO of Burrill and Company, a diversified global financial-services firm focused on the life-sciences industry, and serves on the boards of directors of Catalyst Biosciences, Depomed, NewBridge, Novadaq, Proventys, Targacept, and XDx.
Before founding Burrill and Company in 1994, he spent 28 years with Ernst and Young, directing and coordinating the firm’s services to clients in the biotechnology, life-sciences, high-technology, and manufacturing industries worldwide. In 2002 Burrill was recognized as a biotech-investment visionary by Scientific American. In 2008 he received the BayBio Pantheon DiNA lifetime-achievement award for his worldwide biotech leadership.
In addition to his work with leading life-sciences companies Burrill is a founder and currently chairman of the board of the Foundation for the National Medals of Science and Technology. He also serves as chairman of the San Francisco Mayor’s Biotech Advisory Committee. Burrill chaired the National Research Council study on links in biotechnology between Japan and the United States and also serves on the board of directors of the MIT Center for Biomedical Innovation, the National Health Museum (vice chairman), the World Council for Ethical Standards (chairman), the Scientific American Board of Advisers, and the Harvard Medical School Genetics Advisory Council.
Arnold Thackray founded the Chemical Heritage Foundation and served the organization as president for 25 years. He is currently CHF’s chancellor. Thackray received M.A. and Ph.D. degrees in history of science from Cambridge University. He has held appointments at Cambridge, Oxford University, and Harvard University, the Institute for Advanced Study, the Center for Advanced Study in the Behavioral Sciences, and the Hebrew University of Jerusalem.
In 1983 Thackray received the Dexter Award from the American Chemical Society for outstanding contributions to the history of chemistry. He served for more than a quarter century on the faculty of the University of Pennsylvania, where he was the founding chairman of the Department of History and Sociology of Science and is currently the Joseph Priestley Professor Emeritus.